- The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary Study
-
Kim JH, Seo HW, Han HC, Lee JH, Choi SK, Lee D
- KMID: 1705418
- Korean J Ophthalmol.
- 2013 Aug;27(4):235-242.
- doi: 10.3341/kjo.2013.27.4.235
PURPOSE: To compare the short term effects of bevacizumab and ranibizumab injections on the regression of corneal neovascularization (NV). METHODS: Sixteen eyes of 16 patients with corneal NV were randomly assigned... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Smoking Is Associated with a Poor Visual Acuity Improvement after Intravitreal Ranibizumab Therapy in Patients with Exudative Age-Related Macular Degeneration
-
Lee S, Song SJ, Yu HG
- KMID: 1777567
- J Korean Med Sci.
- 2013 May;28(5):769-774.
- doi: 10.3346/jkms.2013.28.5.769
In this study, the risk factors that may influence visual improvement after intravitreal ranibizumab (IVR) treatment for exudative age-related macular degeneration (AMD) were examined. From 2008 to 2012, 420 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea
-
Cheong HI, Jo SK, Yoon SS, Cho H, Kim JS, Kim YO, Koo JR, Park Y, Park YS, Shin JI, Yoo KH, Oh D
- KMID: 2468240
- J Korean Med Sci.
- 2016 Oct;31(10):1516-1528.
- doi: 10.3346/jkms.2016.31.10.1516
Atypical hemolytic uremic syndrome (aHUS) is a rare syndrome characterized by micro-angiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. The major pathogenesis of aHUS involves dysregulation of the complement system.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Idiopathic Central Serous Chorioretinopathy in a 12-year-old Male Treated with Bevacizumab
-
Kim YC, Kim SD, Kim KS
- KMID: 1397492
- Korean J Ophthalmol.
- 2012 Oct;26(5):391-393.
- doi: 10.3341/kjo.2012.26.5.391
A 12-year-old male presented with a chief complaint of a 1-month-history of decreased visual acuity in his right eye. The patient had no past history of steroid use or other... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Cholesterosis Bulbi with Secondary Glaucoma Treated by Vitrectomy and Intravitreal Bevacizumab
-
Park J, Lee H, Kim YK, Chae JD, Lee HJ
- KMID: 1098643
- Korean J Ophthalmol.
- 2011 Oct;25(5):362-365.
- doi: 10.3341/kjo.2011.25.5.362
We report on a case of cholesterosis bulbi concurrent with secondary glaucoma. A 36-year-old man, with a history of long-standing retinal detachment in his right eye after the irrigation and... -
- CITED
-
- Close
- SHARE
-
- Close
- Dual-Energy CT in Patients Treated with Anti-Angiogenic Agents for Non-Small Cell Lung Cancer: New Method of Monitoring Tumor Response?
-
Kim YN, Lee HY, Lee KS, Seo JB, Chung MJ, Ahn MJ, Park K, Kim TS, Yi CA
- KMID: 1397500
- Korean J Radiol.
- 2012 Dec;13(6):702-710.
- doi: 10.3348/kjr.2012.13.6.702
OBJECTIVE: To evaluate tumor responses in patients treated with anti-angiogenic agents for non-small cell lung cancer (NSCLC) by assessing intratumoral changes using a dual-energy CT (DECT) (based on Choi's criteria)... -
- CITED
-
- Close
- SHARE
-
- Close
